Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 10, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Journal: The New England journal of medicine
Published: July 14, 2021
Showing 1-2 of 2
Last Updated: 09/26/2026